AUD 0.46
(-1.09%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 58.97 Million AUD | 18.32% |
2023 | 49.84 Million AUD | 15.15% |
2022 | 43.28 Million AUD | 25.26% |
2021 | 34.55 Million AUD | 11.63% |
2020 | 30.95 Million AUD | -8.38% |
2019 | 33.78 Million AUD | 12.35% |
2018 | 30.07 Million AUD | -7.97% |
2017 | 32.67 Million AUD | 31.25% |
2016 | 24.89 Million AUD | 31.57% |
2015 | 18.92 Million AUD | 14.04% |
2014 | 16.59 Million AUD | 37.75% |
2013 | 12.04 Million AUD | 20.68% |
2012 | 9.98 Million AUD | 27.44% |
2011 | 7.83 Million AUD | 25.23% |
2010 | 6.25 Million AUD | -0.5% |
2009 | 6.28 Million AUD | 30.14% |
2008 | 4.83 Million AUD | 9.53% |
2007 | 4.4 Million AUD | -17.65% |
2006 | 5.35 Million AUD | 46.3% |
2005 | 3.66 Million AUD | 577.37% |
2004 | 540.37 Thousand AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 FY | 57.67 Million AUD | 15.71% |
2024 Q4 | 28.51 Million AUD | 0.0% |
2024 Q2 | 29.15 Million AUD | 0.0% |
2023 Q4 | 25.47 Million AUD | 0.0% |
2023 Q2 | 24.36 Million AUD | 0.0% |
2023 FY | 49.84 Million AUD | 15.15% |
2022 Q2 | 21.65 Million AUD | 0.0% |
2022 Q4 | 22.27 Million AUD | 0.0% |
2022 FY | 43.28 Million AUD | 25.26% |
2021 FY | 34.55 Million AUD | 11.63% |
2021 Q2 | 15.51 Million AUD | 0.0% |
2021 Q4 | 19.03 Million AUD | 0.0% |
2020 Q2 | 16.65 Million AUD | 0.0% |
2020 Q4 | 14.29 Million AUD | 0.0% |
2020 FY | 30.95 Million AUD | -8.38% |
2019 Q4 | 16.84 Million AUD | 0.0% |
2019 FY | 33.78 Million AUD | 12.35% |
2019 Q2 | 16.94 Million AUD | 0.0% |
2018 FY | 30.07 Million AUD | -7.97% |
2018 Q2 | 14.76 Million AUD | 0.0% |
2018 Q4 | 15.3 Million AUD | 0.0% |
2017 Q2 | 14.13 Million AUD | 0.0% |
2017 FY | 32.67 Million AUD | 31.25% |
2017 Q4 | 18.54 Million AUD | 0.0% |
2016 Q2 | 12.03 Million AUD | 0.0% |
2016 Q4 | 12.86 Million AUD | 0.0% |
2016 FY | 24.89 Million AUD | 31.57% |
2015 FY | 18.92 Million AUD | 14.04% |
2015 Q4 | 9.41 Million AUD | 0.0% |
2015 Q2 | 9.5 Million AUD | 0.0% |
2014 FY | 16.59 Million AUD | 37.75% |
2014 Q4 | 8.82 Million AUD | 0.0% |
2014 Q2 | 7.77 Million AUD | 0.0% |
2013 Q2 | 5.6 Million AUD | 0.0% |
2013 FY | 12.04 Million AUD | 20.68% |
2013 Q4 | 6.43 Million AUD | 0.0% |
2012 Q4 | 2.49 Million AUD | 0.0% |
2012 Q1 | 575.78 Thousand AUD | 0.0% |
2012 Q3 | 2.49 Million AUD | 0.0% |
2012 FY | 9.98 Million AUD | 27.44% |
2012 Q2 | 2.49 Million AUD | 333.38% |
2011 FY | 7.83 Million AUD | 25.23% |
2011 Q1 | 1.56 Million AUD | 0.0% |
2011 Q2 | 575.78 Thousand AUD | -63.18% |
2011 Q3 | 575.78 Thousand AUD | 0.0% |
2011 Q4 | 575.78 Thousand AUD | 0.0% |
2010 Q4 | 1.56 Million AUD | 0.0% |
2010 Q1 | 1.57 Million AUD | 0.0% |
2010 Q2 | 1.56 Million AUD | -0.5% |
2010 Q3 | 1.56 Million AUD | 0.0% |
2010 FY | 6.25 Million AUD | -0.5% |
2009 Q1 | 1.2 Million AUD | 0.0% |
2009 Q3 | 1.57 Million AUD | 0.0% |
2009 Q4 | 1.57 Million AUD | 0.0% |
2009 FY | 6.28 Million AUD | 30.14% |
2009 Q2 | 1.57 Million AUD | 30.14% |
2008 Q4 | 1.2 Million AUD | 0.0% |
2008 Q3 | 1.2 Million AUD | 0.0% |
2008 Q2 | 1.2 Million AUD | 470.76% |
2008 Q1 | 211.56 Thousand AUD | 0.0% |
2008 FY | 4.83 Million AUD | 9.53% |
2007 Q1 | 1.3 Million AUD | 0.0% |
2007 FY | 4.4 Million AUD | -17.65% |
2007 Q3 | 211.56 Thousand AUD | 0.0% |
2007 Q4 | 211.56 Thousand AUD | 0.0% |
2007 Q2 | 211.56 Thousand AUD | -83.77% |
2006 Q3 | 1.3 Million AUD | 0.0% |
2006 Q2 | 1.3 Million AUD | 225.18% |
2006 Q4 | 1.3 Million AUD | 0.0% |
2006 FY | 5.35 Million AUD | 46.3% |
2006 Q1 | 400.78 Thousand AUD | 0.0% |
2005 Q4 | 400.78 Thousand AUD | 0.0% |
2005 FY | 3.66 Million AUD | 577.37% |
2005 Q3 | 400.78 Thousand AUD | 0.0% |
2005 Q1 | 83.61 Thousand AUD | 0.0% |
2005 Q2 | 400.78 Thousand AUD | 379.3% |
2004 Q2 | 83.61 Thousand AUD | 0.0% |
2004 Q4 | 83.61 Thousand AUD | 0.0% |
2004 FY | 540.37 Thousand AUD | 0.0% |
2004 Q3 | 83.61 Thousand AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | -87.311% |
Adherium Limited | 267.7 Thousand AUD | -21929.092% |
Aroa Biosurgery Limited | 66.09 Million AUD | 10.783% |
Atomo Diagnostics Limited | 1.6 Million AUD | -3572.007% |
Anteris Technologies Ltd | 69.14 Million AUD | 14.718% |
Control Bionics Limited | 9.82 Million AUD | -500.173% |
CardieX Limited | 16.64 Million AUD | -254.211% |
Compumedics Limited | 26.88 Million AUD | -119.392% |
Cochlear Limited | 1.17 Billion AUD | 94.979% |
CleanSpace Holdings Limited | 11.35 Million AUD | -419.156% |
Cyclopharm Limited | 13.38 Million AUD | -340.724% |
EMVision Medical Devices Ltd | 12.83 Million AUD | -359.516% |
Nova Eye Medical Limited | 23.99 Million AUD | -145.821% |
HeraMED Limited | 6.78 Million AUD | -769.422% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 5385.04% |
ImpediMed Limited | 28.04 Million AUD | -110.308% |
InhaleRx Limited | 2.59 Million AUD | -2176.464% |
LBT Innovations Limited | 1.1 Million AUD | -5227.239% |
Micro-X Limited | 18.76 Million AUD | -214.286% |
Neurotech International Limited | 8.75 Million AUD | -573.641% |
OncoSil Medical Limited | 12.03 Million AUD | -389.812% |
PolyNovo Limited | 34.92 Million AUD | -68.869% |
Respiri Limited | 8.03 Million AUD | -633.959% |
Universal Biosensors, Inc. | 20 Million AUD | -194.859% |
Uscom Limited | 5.52 Million AUD | -968.335% |
Visioneering Technologies, Inc. | 9.63 Million AUD | -512.152% |